The invention provides heteroarylene substituted 8-azabicyclo[3.2.1]octane compounds of formula (I):
wherein R
1
, R
2
, A, and m are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are antagonists at the mu opioid receptor. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat conditions associated with mu opioid receptor activity, and processes and intermediates useful for preparing such compounds.
本发明提供了异
芳烃取代的8-
氮杂
双环[3.2.1]辛烷化合物,其
化学式为(I):其中R1、R2、A和m在说明书中定义,或其药学上可接受的盐,是μ阿片受体
拮抗剂。本发明还提供了包含这种化合物的制药组合物、使用这种化合物治疗与μ阿片受体活性相关的疾病的方法,以及用于制备这种化合物的过程和
中间体。